Skip NavigationSkip to Content

The Ev-O-Derived Cell Line Df-1 Supports the Efficient Replication of Avian Leukosis-Sarcoma Viruses and Vectors

  1. Author:
    Schaeferklein, J.
    Givol, I.
    Barsov, E. V.
    Whitcomb, J. M.
    Vanbrocklin, M.
    Foster, D. N.
    Federspiel, M. J.
    Hughes, S. H.
  2. Author Address

    Hughes SH NCI FREDERICK CANC RES & DEV CTR RETROVIRAL REPLICAT & VECTOR DESIGN SECT FREDERICK, MD 21702 USA NCI FREDERICK CANC RES & DEV CTR RETROVIRAL REPLICAT & VECTOR DESIGN SECT ABL BASIC RES PROGRAM FREDERICK, MD 21702 USA MAYO CLIN & MAYO FDN PROGRAM MOL MED ROCHESTER, MN 55905 USA VIROLOG INC S SAN FRANCISCO, CA 94080 USA UNIV MINNESOTA DEPT ANIM SCI ST PAUL, MN 55108 USA
    1. Year: 1998
  1. Journal: Virology
    1. 248
    2. 2
    3. Pages: 305-311
  2. Type of Article: Article
  1. Abstract:

    The lack of a well-behaved permanent, adherent, nontransformed chicken cell line has made some experiments with avian leukosis-sarcoma viruses (ASLV) and vectors considerably more difficult. The EV-O-derived line, DF-I, supports the efficient replication of subgroups (A), (B), and (C) ASLV, as well as amphotrophic murine leukemia virus and an ASLV-derived vector that has its env gene derived from the env gene from an amphotrophic murine leukemia virus. The cell line responds appropriately to the expression of a transforming oncogene (v-myc) to a growth suppressor gene [p21(wail)] and can be sorted (using FAGS) ii infected by an ASLV vector that expresses GFP. (C) 1998 Academic Press. [References: 13]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel